Annovis Bio, Inc.ANVSNYSE
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank75
3Y CAGR-15.9%
5Y CAGR+17.4%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-15.9%/yr
Annual compound
5Y CAGR
+17.4%/yr
Recent deceleration
Percentile
P75
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$16.85M+81.0%
2024$9.31M+220.1%
2023$-7.75M-127.4%
2022$28.32M-36.3%
2021$44.49M+490.0%
2020$7.54M+187.9%
2019$-8.58M-12.9%
2018$-7.59M-9.0%
2017$-6.97M-